Gf Fund Management »

Rapt Therapeutics shares owned by Gf Fund Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Gf Fund Management from 13F filings

Historical chart of Gf Fund Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Gf Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Gf Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $18k 544 33.87

More positions owned by Gf Fund Management

NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOG)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Tesla Common Stock (TSLA)
Meta Platforms Common Stock (META)
Lumentum Holdings Common Stock (LITE)
Alphabet Common Stock (GOOGL)
PDD Holdings Adr (PDD)
Sandisk Corp Common Stock (SNDK)
Micron Technology Common Stock (MU)
Costco Wholesale Corp Common Stock (COST)
Palantir Technologies Common Stock (PLTR)

View all positions for Gf Fund Management

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics